Skip to main content
. 2005 Nov 10;3:Doc09.

Figure 1. FACS analysis of HUCB cells used for treatment.

Figure 1

Left panel shows a CD34+ cell depleted sample stained with an anti-CD34 antibody (0.4% CD34+ cells) directed to a non-competing CD34 epitope as compared to the antibody used for cell separation. Right panel shows a CD34+ cell enriched fraction (98.9%).